Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Publication Information:
      Springer Healthcare, 2020.
    • Publication Date:
      2020
    • Abstract:
      Introduction The safety and efficacy of exenatide once weekly (EQW) is overall well established. EQW is primarily renally eliminated. In this study, the efficacy and renal and gastrointestinal tolerability of EQW were summarised in participants with type 2 diabetes and chronic kidney disease stage 3 (CKD3; moderate renal impairment; estimated glomerular filtration rate [eGFR] ≥ 30 to
    • ISSN:
      1869-6961
      1869-6953
    • Rights:
      OPEN
    • Accession Number:
      edsair.doi.dedup.....38b1649b5f1cf7be8b0d9adf013961c4